Sigma Pharmaceuticals plc is pleased to announce the successful completion of a refinance, securing a new bilateral asset-based lending facility with Bank Leumi ABL. This new agreement provides Sigma with a bilateral 4-year committed facility, which will be instrumental in supporting the company’s continued growth and future business development.
We extend our sincere gratitude to Bank Leumi ABL for their partnership. This refinance deal is a testament to the strong relationship we have developed over the past three years and we look forward to continuing our collaboration.
We would also like to thank ABN Amro Commercial Finance for their support over the last three years in leading the previous club facility alongside Bank Leumi ABL. Their commitment to our business has been greatly appreciated.
Furthermore, we would like to express our thanks to the teams at PWC and Pinsent Masons for their invaluable advice and support throughout this transaction. Their expertise was crucial in achieving this positive outcome.
